RKDA
Arcadia Biosciences, Inc.
Key Financials
Operating Income
$-2500000
↑ 31.5%
Net Income
$-2339000
↑ 66.8%
Revenue
$4.9M
↓ 3.7%
Total Assets
$6.5M
↓ 51.6%
EPS (Diluted)
$-1.71
↑ 66.9%
Shareholders' Equity
$6.2M
↓ 51.5%
Cash & Equivalents
$259000.00
↓ 93.9%
Total Liabilities
$2.4M
↓ 67.0%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| SCHEDULE 13G/A | 8/14/2026 | View on SEC |
| 10-Q | 8/13/2026 | View on SEC |
| 8-K | 8/13/2026 | View on SEC |
| ARS | 8/10/2026 | View on SEC |
| DEF 14A | 8/10/2026 | View on SEC |
| 8-K | 8/10/2026 | View on SEC |
| PRE 14A | 7/31/2026 | View on SEC |
| 424B3 | 7/9/2026 | View on SEC |
| EFFECT | 7/8/2026 | View on SEC |
| 8-K | 7/2/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | RKDA |
| Company Name | Arcadia Biosciences, Inc. |
| CIK | 1469443 |
| Sector | Crude Petroleum & Natural Gas |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | Nasdaq |
| SIC Code | 1311 |
| SIC Description | Crude Petroleum & Natural Gas |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 214-974-8921 |